KTTA logo

Pasithea Therapeutics Corp. (KTTA)

Profile

Full Name

Pasithea Therapeutics Corp.

Ticker

NASDAQ: KTTA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 15, 2021

Indexes

Not included

Website

https://www.pasithea.com

Employees

4

Key Details

Price

$1.06(117.39%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$12.69(2.52% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.06
    KTTA price is $1.06

    30-Day Relative Volume

    19.05
    KTTA 30-day relative volume is 19.05

    Price Performance

    Price Most Recent Change

    +117.39%
    KTTA price was up +117.39% on Nov 26, 2025

    Price YTD Change

    -66.35%
    KTTA price is down -66.35% since January 1st

    Price 1-Year Change

    -64.78%
    KTTA price is down -64.78% year-on-year

    Price 3-Year Change

    -94.75%
    KTTA price is down -94.75% over the past 3 years

    Price Range

    Price All-Time High

    $170.00
    KTTA price is currently -99.38% below its historical high of $170.00

    Price 3-Year Low

    $0.28
    KTTA price is currently +277.22% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $7.89M
    KTTA market cap is $7.89 million

    Market Cap 3-Year Change

    -73.29%
    KTTA market cap is down -73.29% over the past 3 years

    Market Cap All-Time High

    $93.02M
    KTTA market cap is currently -91.52% below its historical high of $93.02 million

    Market Cap Sector Percentile

    14.97%
    KTTA market cap is higher than 14.97% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +487.78%
    KTTA shares outstanding is up +487.78% year-on-year

    Shares Outstanding 3-Year Change

    +409%
    KTTA shares outstanding is up +409% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -0.26
    KTTA beta is -0.26

    200-day SMA

    $0.92
    KTTA price is currently +14.97% above its 200-day simple moving average

    50-day SMA

    $0.72
    KTTA price is currently +47.74% above its 50-day simple moving average

    14-Day RSI

    67.27
    KTTA 14-day relative strength index is 67.27

    Volume

    19.05
    KTTA 30-day relative volume is 19.05

    ATR

    $0.15
    KTTA average true range is $0.15

    10-day Historical Volatility

    688.36%
    KTTA 10-day historical volatility is 688.36%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    KTTA annual revenue is $0.00

    Revenue Analysts Estimate

    -
    KTTA annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    0%
    KTTA annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.31%
    KTTA annual revenue is higher than 28.31% of companies in Healthcare sector

    EPS

    EPS

    -$12.69
    KTTA annual earnings per share is -$12.69

    EPS Analysts Estimate

    -
    KTTA annual earnings per share consensus analysts' forecast is unknown

    EPS 1-Year Change

    +2.52%
    KTTA annual earnings per share is up +2.52% year-on-year

    EPS Sector Percentile

    12.68%
    KTTA annual earnings per share is higher than 12.68% of companies in Healthcare sector

    Profit

    Gross Profit

    -$649.00K
    KTTA annual gross profit is -$649.00 thousand

    Gross Margin

    -
    KTTA annual gross profit margin value is unknown

    Operating Profit

    -$14.25M
    KTTA annual operating income is -$14.25 million

    Operating Margin

    -
    KTTA annual operating profit margin value is unknown

    Net Income

    -$13.90M
    KTTA annual net profit is -$13.90 million

    Net Margin

    -
    KTTA annual net profit margin value is unknown

    Expenses

    Total Expenses

    $13.90M
    KTTA annual total expenses is $13.90 million

    Operating Expenses

    $13.60M
    KTTA annual total operating expenses is $13.60 million

    Cost Of Goods Sold

    $649.00K
    KTTA annual cost of goods sold is $649.00 thousand

    Selling, General & Administrative Expenses

    $0.00
    KTTA annual SG&A is $0.00

    Depreciation & Amortization

    $649.00K
    KTTA annual D&A is $649.00 thousand

    Interest Expense

    $0.00
    KTTA annual interest expense is $0.00

    Income Tax

    $0.00
    KTTA annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$14.25M
    KTTA annual earnings before interest & taxes is -$14.25 million

    EBITDA

    -$13.60M
    KTTA annual EBITDA is -$13.60 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $16.06M
    KTTA annual total assets is $16.06 million

    Non Current Assets

    $8.70M
    KTTA annual long term assets is $8.70 million

    Current Assets

    $7.37M
    KTTA annual total current assets is $7.37 million

    Cash and Cash Equivalents

    $6.92M
    KTTA annual cash & cash equivalents is $6.92 million

    Accounts Receivable

    -
    KTTA annual accounts receivable value is unknown

    Inventory

    $0.00
    KTTA annual inventory is $0.00

    Liabilities

    Total Liabilities

    $1.28M
    KTTA annual total liabilities is $1.28 million

    Long Term Liabilities

    $162.20K
    KTTA annual total long term liabilities is $162.20 thousand

    Current Liabilities

    $1.12M
    KTTA annual current liabilities is $1.12 million

    Accounts Payable

    $0.00
    KTTA annual accounts payable is $0.00

    Debt

    Total Debt

    $0.00
    KTTA annual total debt is $0.00

    Total Debt 1-Year Change

    -100%
    KTTA annual total debt is down -100% year-on-year

    Long Term Debt

    $0.00
    KTTA annual long term debt is $0.00

    Short Term Debt

    $0.00
    KTTA annual short term debt is $0.00

    Equity & Capital

    Shareholders Equity

    $14.78M
    KTTA annual stockholders equity is $14.78 million

    Book Value

    $14.78M
    KTTA annual book value is $14.78 million

    Retained Earnings

    -$49.58M
    KTTA annual retained earnings is -$49.58 million

    Working Capital

    $6.25M
    KTTA annual working capital is $6.25 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$13.92M
    KTTA annual cash from operations is -$13.92 million

    Cash From Operations 1-Year Change

    -3.71%
    KTTA annual cash from operations is down -3.71% year-on-year

    Cash From Investing

    $0.00
    KTTA annual cash from investing is $0.00

    Cash From Investing 1-Year Change

    -100%
    KTTA annual cash from investing is down -100% year-on-year

    Cash From Financing

    $4.52M
    KTTA annual cash from financing is $4.52 million

    Cash From Financing 1-Year Change

    +221.23%
    KTTA annual cash from financing is up +221.23% year-on-year

    CAPEX

    CAPEX

    $0.00
    KTTA annual capital expenditures is $0.00

    CAPEX 1-Year Change

    -100%
    KTTA annual capital expenditures is down -100% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$13.92M
    KTTA annual free cash flow is -$13.92 million

    Free Cash Flow 1-Year Change

    -3.45%
    KTTA annual free cash flow is down -3.45% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    KTTA annual gross profit margin value is unknown

    Operating Margin

    -
    KTTA annual operating profit margin value is unknown

    Net Margin

    -
    KTTA annual net profit margin value is unknown

    ROA & ROE

    ROA

    -65.93%
    KTTA annual return on assets is -65.93%

    ROE

    -72.83%
    KTTA annual return on equity is -72.83%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    KTTA price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    KTTA price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    0.65
    KTTA price to book ratio is 0.65

    PB Ratio Sector Percentile

    28.89%
    KTTA price to book ratio is higher than 28.89% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    KTTA price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    KTTA price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $3.71M
    KTTA enterprise value is $3.71 million

    Enterprise Value Sector Percentile

    15.53%
    KTTA enterprise value is higher than 15.53% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.28
    KTTA EV/EBITDA is -0.28

    EV/EBITDA Sector Percentile

    57.39%
    KTTA EV/EBITDA is higher than 57.39% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    6.58
    KTTA annual current ratio is 6.58

    Quick Ratio

    6.58
    KTTA annual quick ratio is 6.58

    Leverage

    Debt To Equity

    0.00
    KTTA annual debt to equity ratio is 0.00

    Interest Coverage Ratio

    -
    KTTA annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    KTTA piotroski f-score value is unknown

    Altman Z-Score

    -3.09
    KTTA altman z-score is -3.09

    Analyst ratings

    Recent major analysts updates

    Jul 10, 23 EF Hutton
    Buy
    Apr 3, 23 EF Hutton
    Buy
    Dec 14, 21 EF Hutton
    Buy

    Institutional Ownership

    Screeners with KTTA included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Pasithea Therapeutics Corp.?
    • Does Pasithea Therapeutics Corp. pay dividends?
    • What sector is Pasithea Therapeutics Corp. in?
    • What industry is Pasithea Therapeutics Corp. in?
    • What country is Pasithea Therapeutics Corp. based in?
    • When did Pasithea Therapeutics Corp. go public?
    • Is Pasithea Therapeutics Corp. in the S&P 500?
    • Is Pasithea Therapeutics Corp. in the NASDAQ 100?
    • Is Pasithea Therapeutics Corp. in the Dow Jones?
    • When was Pasithea Therapeutics Corp.'s last earnings report?
    • When does Pasithea Therapeutics Corp. report earnings?

    What is the ticker symbol for Pasithea Therapeutics Corp.?

    The ticker symbol for Pasithea Therapeutics Corp. is NASDAQ:KTTA

    Does Pasithea Therapeutics Corp. pay dividends?

    No, Pasithea Therapeutics Corp. does not pay dividends

    What sector is Pasithea Therapeutics Corp. in?

    Pasithea Therapeutics Corp. is in the Healthcare sector

    What industry is Pasithea Therapeutics Corp. in?

    Pasithea Therapeutics Corp. is in the Biotechnology industry

    What country is Pasithea Therapeutics Corp. based in?

    Pasithea Therapeutics Corp. is headquartered in United States

    When did Pasithea Therapeutics Corp. go public?

    Pasithea Therapeutics Corp.'s initial public offering (IPO) was on September 15, 2021

    Is Pasithea Therapeutics Corp. in the S&P 500?

    No, Pasithea Therapeutics Corp. is not included in the S&P 500 index

    Is Pasithea Therapeutics Corp. in the NASDAQ 100?

    No, Pasithea Therapeutics Corp. is not included in the NASDAQ 100 index

    Is Pasithea Therapeutics Corp. in the Dow Jones?

    No, Pasithea Therapeutics Corp. is not included in the Dow Jones index

    When was Pasithea Therapeutics Corp.'s last earnings report?

    Pasithea Therapeutics Corp.'s most recent earnings report was on November 13, 2025

    When does Pasithea Therapeutics Corp. report earnings?

    The date for Pasithea Therapeutics Corp.'s next earnings report has not been announced yet
    On this page